KLAC
47
4
HBI
59
4
LNC
39
3
HSIC
56
5
AON
54
2
MA
64
7
FSLR
54
7
PAYX
53
2
HCA
44
-2
BWA
48
2
LYB
39
2
DE
63
3
M
37
12
HPE
63
2
ROP
62
3
SYK
64
-4
JPM
69
2
PFG
45
3
BBY
46
10
A
43
2
KLAC
47
4
HBI
59
4
LNC
39
3
HSIC
56
5
AON
54
2
MA
64
7
FSLR
54
7
PAYX
53
2
HCA
44
-2
BWA
48
2
LYB
39
2
DE
63
3
M
37
12
HPE
63
2
ROP
62
3
SYK
64
-4
JPM
69
2
PFG
45
3
BBY
46
10
A
43
2
Financhill
Back

EyePoint Pharmaceuticals Vs. Editas Medicine Industry Stock Comparison

Buy
61

EYPT
EyePoint Pharmaceuticals

Last Price:
8.94
Seasonality Move:
28.93%
Sell
40

EDIT
Editas Medicine

Last Price:
2.44
Seasonality Move:
13.73%
Buy
61
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.95. The Score for EYPT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $2.44. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $2.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight buying pressure.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 41.34 Sell
Chaikin Money Flow: 378625 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.4 - 11.84) Sell
Bollinger Bands (100): (8.13 - 10.51) Sell

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 33.29 Sell
Chaikin Money Flow: 166015 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.64 - 3.32) Sell
Bollinger Bands (100): (2.97 - 4.75) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.31 Sell
20-day SMA: 10.76 Sell
50-day SMA: 9.77 Sell
200-day SMA: 13.45 Sell
8-day EMA: 9.35 Sell
20-day EMA: 10.02 Sell
50-day EMA: 9.94 Sell
200-day EMA: 11.46 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.58 Sell
20-day SMA: 2.89 Sell
50-day SMA: 3.21 Sell
200-day SMA: 5.21 Sell
8-day EMA: 2.58 Sell
20-day EMA: 2.83 Sell
50-day EMA: 3.21 Sell
200-day EMA: 4.98 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):